Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Quantitative computed tomography in pediatric patients.

Gervais-André L, Vija L, Franchi-Abella S, Gonzales E, Linglart A, Adamsbaum C.

Diagn Interv Imaging. 2016 Apr;97(4):499-502. doi: 10.1016/j.diii.2015.08.008. Epub 2016 Feb 5. No abstract available.

2.

Cushing syndrome secondary to ectopic adrenocorticotropic hormone secretion from a Meckel diverticulum neuroendocrine tumor: case report.

Paun DL, Vija L, Stan E, Banica A, Bobeica E, Terzea D, Poiana C, Badiu C, Paun S.

BMC Endocr Disord. 2015 Nov 26;15:72. doi: 10.1186/s12902-015-0070-x.

3.
4.

Ligand-dependent stabilization of androgen receptor in a novel mouse ST38c Sertoli cell line.

Vija L, Boukari K, Loosfelt H, Meduri G, Viengchareun S, Binart N, Young J, Lombès M.

Mol Cell Endocrinol. 2014 Mar 25;384(1-2):32-42. doi: 10.1016/j.mce.2014.01.008. Epub 2014 Jan 16.

PMID:
24440575
5.

Expression and characterization of androgen receptor coregulators, SRC-2 and HBO1, during human testis ontogenesis and in androgen signaling deficient patients.

Vija L, Meduri G, Comperat E, Vasiliu V, Izard V, Ferlicot S, Boukari K, Camparo P, Viengchareun S, Constancis E, Dumitrache C, Lombès M, Young J.

Mol Cell Endocrinol. 2013 Aug 15;375(1-2):140-8. doi: 10.1016/j.mce.2013.05.004. Epub 2013 May 24.

PMID:
23707616
6.

Additional diagnostic value of hybrid SPECT-CT systems imaging in patients with differentiated thyroid cancer.

Toubert ME, Vija L, Vercellino L, Banayan S, Faugeron I, Berenger N, Meas T, Marzola MC, Chondrogiannis S, Hindié E, Rubello D.

Am J Clin Oncol. 2014 Jun;37(3):305-13. doi: 10.1097/COC.0b013e3182568fdb. Review.

PMID:
22781388
7.

Familial isolated primary hyperparathyroidism due to HRPT2 mutation.

Ghemigian A, Ghemigian M, Popescu I, Vija L, Petrova E, Dumitru N, Dumitru I.

Hormones (Athens). 2013 Jul-Sep;12(3):454-60.

8.

Healthy birth after testicular extraction of sperm and ICSI from an azoospermic man with mild androgen insensitivity syndrome caused by an androgen receptor partial loss-of-function mutation.

Massin N, Bry H, Vija L, Maione L, Constancis E, Haddad B, Morel Y, Claessens F, Young J.

Clin Endocrinol (Oxf). 2012 Oct;77(4):593-8. doi: 10.1111/j.1365-2265.2012.04402.x.

PMID:
22469007
9.

Mesenchymal stem cells: Stem cell therapy perspectives for type 1 diabetes.

Vija L, Farge D, Gautier JF, Vexiau P, Dumitrache C, Bourgarit A, Verrecchia F, Larghero J.

Diabetes Metab. 2009 Apr;35(2):85-93. doi: 10.1016/j.diabet.2008.10.003. Epub 2009 Feb 20. Review.

PMID:
19230736
10.

Evidence of an antifibrotic effect of immunosuppressive drugs: applications in the treatment of systemic sclerosis.

Verrecchia F, Wang Y, Vija L, Farge D.

Expert Rev Clin Immunol. 2009 Jan;5(1):35-43. doi: 10.1586/1744666X.5.1.35.

PMID:
20476898
11.

[Mesenchymal stem cells and immunomodulation: toward new immunosuppressive strategies for the treatment of autoimmune diseases?].

Larghero J, Vija L, Lecourt S, Michel L, Verrecchia F, Farge D.

Rev Med Interne. 2009 Mar;30(3):287-99. doi: 10.1016/j.revmed.2008.08.019. Epub 2008 Oct 17. Review. French.

PMID:
18930338

Supplemental Content

Loading ...
Support Center